Elevance Health, Inc. - 8-K Filing

Elevance Health reports Q3 revenue of $50.4B and raises FY2026 EPS guidance to at least $29 (Items: 2.02 or Exhibit 99, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $ELV

Read the full article at SEC EDGAR

More Regulatory news